|
(P1089) |
Novalgin and aspirin antiplatelet effects in stroke patients |
| |
|
L. K. Dannenberg, V. Erschoff, M. Gliem, S. Jander, B. Levkau, M. Kelm, T. Hohlfeld, T. Zeus, A. Polzin (Düsseldorf, Essen) |
|
(P1090) |
Combined administration of the GPVI-Fc fusion protein Revacept with low dose thrombolytic therapy in the treatment of stroke |
| |
|
M. Ungerer, Z. Li, A. Reimann, M. Gawaz, G. Münch (Martinsried, Tübingen) |
|
(P1091) |
Incidence, Risk Factors and Association With Clinical Events of Embolic Debris in Over 900 Carotid Artery Stenting Procedures |
| |
|
J. Ledwoch, S. Staubach, M. Segerer, M. Hug, H. Mudra (München) |
|
(P1092) |
Long-term Outcome of Patients Undergoing Carotid Artery Stenting in High-volume Centres |
| |
|
J. Ledwoch, K. Bijuklic, M. Segerer, H. Mudra, J. Schofer (München, Hamburg) |
|
(P1093) |
Carotid Artery Stenting in the Real World: Poor Acute And Longterm Outcome in Patients Ineligible for Randomized Controlled Trials |
| |
|
S. Staubach, J. Ledwoch, M. Segerer, H. Strohm, H. Mudra (München) |
|
(P1094) |
Karotis-PTA bei Patienten mit Restenose nach chirurgischer Endarteriektomie: Analyse eines großen Single-Center Registers |
| |
|
S. Staubach, J. Ledwoch, M. Segerer, H. Strohm, H. Mudra (München) |